CME Sessions at EANM’07

EANM’07 – CME Session VI

Oncology
October 15, 2007, 11:30 – 13:00
Nuclear Medicine in Diagnosis and Treatment of Lymphoma

Moderator: F. Pons (Barcelona)
Co-Moderator: V. Lewington (London)


Speakers:
extended
abstract
F.J. Setoain (Barcelona):
Clinical update of lymphoma. PET for staging
K. Spaepen (Antwerp):
PET for monitoring therapy response
V. Lewington (London):
Radioimmunotherapy in the treatment of lymphoma


Educational objectives:

  1. Know the current clinical classification of lymphomas
  2. Determine the usefulness of PET for staging and its role as an alternative to conventional diagnostic methods
  3. Evaluate the role of PET in therapy monitoring and to know which are the future directions
  4. Know the principles of radioimmunotherapy in lymphoma
  5. Evaluate which patients are candidates for radioimmunotherapy, to know the therapy schedule and how to evaluate the response


Summary:

This continuing education session is designed primarily for physicians with a background in nuclear medicine and oncology who are involved or interested in the field of PET and radio-immunotherapy. It will cover both diagnostic and therapeutic advances in the evaluation of lymphomas by means of nuclear medicine procedures. After giving a general overview of the current state-of-the art of the most relevant clinical aspects of lymphomas, the value of [18F]FDG-PET for staging as well as for therapy response monitoring will be developed. Attendees will also receive updated information on radioimmunotherapy of lymphomas, including the eligibility criteria for treatment, the therapy schedule and its efficacy. Overall, the session is intended to provide an update for the most relevant diagnostic and therapeutic aspects in lymphoma patients.


Key Words:

[18F]FDG-PET, lymphoma, radio-immunotherapy, staging, therapy monitoring

Back to top